Montanaro Asset Management Ltd Sells 75 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Montanaro Asset Management Ltd cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 9.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 700 shares of the biotechnology company’s stock after selling 75 shares during the quarter. Montanaro Asset Management Ltd’s holdings in Axon Enterprise were worth $416,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Public Sector Pension Investment Board grew its stake in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after buying an additional 500 shares during the last quarter. Soros Capital Management LLC bought a new stake in Axon Enterprise during the 3rd quarter worth $630,000. Friedenthal Financial increased its holdings in Axon Enterprise by 961.7% in the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after purchasing an additional 1,231 shares in the last quarter. Principal Financial Group Inc. raised its position in Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after purchasing an additional 33,869 shares during the last quarter. Finally, XTX Topco Ltd boosted its stake in shares of Axon Enterprise by 20.6% during the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock valued at $2,258,000 after purchasing an additional 964 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 3.1 %

Shares of AXON stock opened at $559.06 on Thursday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a 50 day simple moving average of $591.51 and a two-hundred day simple moving average of $546.76. The company has a market cap of $42.84 billion, a P/E ratio of 144.46, a PEG ratio of 5.17 and a beta of 1.12.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on AXON shares. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.